Protosappanin A
Product Specifications
CAS Number
102036-28-2
Target
NF-κB, HIV Protease, IκB/IKK, NADPH-oxidase, IL Receptor, JAK, COX, STAT, ROS, Interleukin, TLR, TNF, NO Synthase
Related Pathways
Neuroscience, Microbiology/Virology, NF-κB, Tyrosine Kinase/Adaptors, Stem Cells, Chromatin/Epigenetic, Apoptosis, Proteases/Proteasome, JAK/STAT signaling, Immunology/Inflammation, Angiogenesis
Purity
>99.99%
Bioactivity
Protosappanin A (PTA) has anti-oxidative/nitrative activities on brain immune and neuroinflammation through regulation of CD14/TLR4-dependent IKK/IÎoB/NF-ÎoB inflammation signal pathway; it exerts anti-neuroinflammatory effect by inhibiting JAK2-STAT3 pathway in lipopolysaccharide-induced BV2 microglia. Protosappanin A induces immunosuppression of rats heart transplantation targeting T cells in grafts via NF-kappaB pathway. Protosappanin A and protosappanin B have antimicrobial activity, they show both alone activities and resistance reversal effects of amikacin and gentamicin against MRSA. Protosappanin A shows strong effect against HIV-1 IN with an IC50 value of 12.6 uM.
Smiles
Oc1ccc-2c(OCC(=O)Cc3cc(O)c(O)cc-23)c1
Molecular Formula
C15H12O5
Molecular Weight
272.25
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15252090 1 Vial
Lentiviral mouse Sost shRNA (UAS) - Lentiviral mouse Sost shRNA (UAS) (100)
Sign In for Pricing
View Details 137111 50 µg
MAGOHB, Recombinant, Human, aa1-148, His-Tag (Protein Mago Nashi Homolog 2, Mago-nashi Homolog B (Drosophila), Mago, Magoh, MGN2)
Sign In for Pricing
View Details